Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1991-8-8
|
pubmed:abstractText |
Lipopolysaccharide (LPS) injected intravenously produces leukopenia and sequestration of polymorphonuclear leukocytes (PMN) in the pulmonary vascular bed. To evaluate the role of complement in this process, we used C5-sufficient (B10.D2/nSn) and C5-deficient (B10.D2/oSn) mice and Sprague-Dawley rats depleted of complement with Naja naja cobra venom factor (CVF). We found a comparable increase in the number of PMN in lung tissue of C5-sufficient and C5-deficient mice given Escherichia coli LPS (0127:B8, 3 mg/kg), revealing that LPS acts independently of C5 and its biologically active fragments. Intravenous injection of LPS (3 mg/kg) into rats caused significant intravascular complement activation as assessed by serum CH50 and resulted in an almost 10-fold increase in numbers of PMN in lung tissue. Pretreatment of rats with CVF (50 U) did not reduce LPS-induced PMN sequestration, suggesting that the process is independent of C3. As reported previously, we found large numbers of PMN in bronchoalveolar lavage samples of 24 h after injection of LPS (3 mg/kg). Complement depletion did not prevent LPS-induced migration of PMN. No PMN migration occurred 2, 6, 12, 24, or 48 h after injection of CVF alone, indicating that complement activation is not sufficient to cause PMN migration. In contrast to our findings in rats, no PMN migrated into airspaces of C5-sufficient and C5-deficient mice 24 or 48 h after injection of LPS (3 to 20 mg/kg).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0003-0805
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
144
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
173-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2064126-Animals,
pubmed-meshheading:2064126-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:2064126-Cell Movement,
pubmed-meshheading:2064126-Cobra Venoms,
pubmed-meshheading:2064126-Complement Activation,
pubmed-meshheading:2064126-Complement C5,
pubmed-meshheading:2064126-Complement Hemolytic Activity Assay,
pubmed-meshheading:2064126-Escherichia coli,
pubmed-meshheading:2064126-Lipopolysaccharides,
pubmed-meshheading:2064126-Lung,
pubmed-meshheading:2064126-Male,
pubmed-meshheading:2064126-Mice,
pubmed-meshheading:2064126-Neutrophils,
pubmed-meshheading:2064126-Rats,
pubmed-meshheading:2064126-Rats, Inbred Strains
|
pubmed:year |
1991
|
pubmed:articleTitle |
Lipopolysaccharide-induced pulmonary vascular sequestration of polymorphonuclear leukocytes is complement independent.
|
pubmed:affiliation |
Department of Medicine, Mount Sinai School of Medicine, New York, New York.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|